Clinical and economic implications of using daratumubab with lenalidomide in the 1st and 2nd lines of therapy for multiple myeloma patients
Article in FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology (May 2024)
The most recent citing publications are shown below. View all 28 publications that cite this research output on Dimensions.
Article in FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology (May 2024)
Article in Orthopaedic Surgery (May 2024)
Article in Gynecologic Oncology (March 2024)